Respiratory heaters sales will grow through 2036, led by chronic obstructive pulmonary disease at a 45.2% share in 2026 as the leading application segment. The market was valued at USD 1.70 million in 2025 and is expected to reach USD 4.85 million by 2036, creating an incremental opportunity of USD 2.98 million.